Incretin mimetic
Incretin mimetic can refer to any drug that mimics the actions of one or more incretin hormones. They are used for type 2 diabetes.[1][2]
Specific incretin mimetics include:
References[edit]
- ^ Research, Center for Drug Evaluation and (2 March 2022). "Incretin mimetic drugs for type 2 diabetes". FDA. Retrieved 5 November 2023.
- ^ "Incretin Based Treatments". Diabetes Education Online. Retrieved 5 November 2023.
This article includes a list of related items that share the same name (or similar names).
If an internal link incorrectly led you here, you may wish to change the link to point directly to the intended article.
If an internal link incorrectly led you here, you may wish to change the link to point directly to the intended article.